NIH-funded research NIH-funded research

Understanding how radiation therapy affects cervical and pancreas tumors

Official title: METEOR-BioLogical Specimen Translation (METEOR-BLST)

Funded at Washington University · NIH-10912708 · Data updated 2026-11-12

This study is looking at how radiation therapy affects cervical and pancreas tumors at different stages, using blood and tumor samples to find out why some cancer cells might survive treatment, with the goal of improving care for patients with these cancers.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$386,855
NIH project number5U54CA274318-02
Project IDNIH-10912708 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with cervical or pancreas tumors who are undergoing or have undergone radiation therapy.

Less likely to help

Patients with tumors not located in the cervix or pancreas, or those who are not receiving radiation therapy, may not benefit from this research.

What this research studies

This research focuses on the molecular characterization of cervical and pancreas tumor specimens at various stages: before, during, and after radiation therapy. By analyzing tumor and blood samples, the project aims to understand how standard chemo-radiation therapy alters the tumor microenvironment, potentially leading to the survival of resistant tumor cells. The research employs advanced techniques such as RNA sequencing, protein mass spectrometry, and spatial metabolomics to gather comprehensive data. This information will help in developing better treatment strategies for patients with these types of cancers.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment approaches for cervical and pancreas cancers, enhancing patient outcomes.

How similar studies have gone: Other research has shown success in using molecular characterization techniques to improve cancer treatment strategies, indicating that this approach has potential.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Major, Michael Benjamin — Washington University
  • Study coordinator: Major, Michael Benjamin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.